Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Fournier

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Hearing Research|June 13, 2012
Gap detection deficits in humans with tinnitus as assessed with the acoustic startle paradigm: does tinnitus fill in the gap?Philippe Fournier, Sylvie Hébert
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2009
Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancerVolker Schirrmacher, Philippe Fournier
Virology|June 27, 2002
Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virusJinyang Zeng, Philippe Fournier, Volker Schirrmacher
Journal of Molecular Medicine (Berlin, Germany)|July 12, 2002
Stimulation of human natural interferon-alpha response via paramyxovirus hemagglutinin lectin-cell interactionJinyang Zeng, Philippe Fournier, Volker Schirrmacher
Vaccine|August 17, 2010
The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccinationJing Ni, Volker Schirrmacher, Philippe Fournier
International Journal of Oncology|September 30, 2010
Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccinePhilippe Fournier, Maximilian Aigner, Volker Schirrmacher
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 9, 2013
The auditory sensitivity is increased in tinnitus earsSylvie Hébert, Philippe Fournier, Arnaud Noreña
Expert Review of Vaccines|November 14, 2013
Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of functionVolker Schirrmacher, Philippe Fournier, Peter Schlag
International Journal of Oncology|July 31, 2003
Two ways to induce innate immune responses in human PBMCs: paracrine stimulation of IFN-alpha responses by viral protein or dsRNAPhilippe Fournier, Jinyang Zeng, Volker Schirrmacher
International Journal of Oncology|July 16, 2004
High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN moleculesJinyang Zeng, Philippe Fournier, Volker Schirrmacher
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Hearing Research|June 13, 2012
Gap detection deficits in humans with tinnitus as assessed with the acoustic startle paradigm: does tinnitus fill in the gap?Philippe Fournier, Sylvie Hébert
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2009
Newcastle disease virus: a promising vector for viral therapy, immune therapy, and gene therapy of cancerVolker Schirrmacher, Philippe Fournier
Virology|June 27, 2002
Induction of interferon-alpha and tumor necrosis factor-related apoptosis-inducing ligand in human blood mononuclear cells by hemagglutinin-neuraminidase but not F protein of Newcastle disease virusJinyang Zeng, Philippe Fournier, Volker Schirrmacher
Journal of Molecular Medicine (Berlin, Germany)|July 12, 2002
Stimulation of human natural interferon-alpha response via paramyxovirus hemagglutinin lectin-cell interactionJinyang Zeng, Philippe Fournier, Volker Schirrmacher
Vaccine|August 17, 2010
The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccinationJing Ni, Volker Schirrmacher, Philippe Fournier
International Journal of Oncology|September 30, 2010
Optimization studies for the coupling of bispecific antibodies to viral anchor molecules of a tumor vaccinePhilippe Fournier, Maximilian Aigner, Volker Schirrmacher
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 9, 2013
The auditory sensitivity is increased in tinnitus earsSylvie Hébert, Philippe Fournier, Arnaud Noreña
Expert Review of Vaccines|November 14, 2013
Autologous tumor cell vaccines for post-operative active-specific immunotherapy of colorectal carcinoma: long-term patient survival and mechanism of functionVolker Schirrmacher, Philippe Fournier, Peter Schlag
International Journal of Oncology|July 31, 2003
Two ways to induce innate immune responses in human PBMCs: paracrine stimulation of IFN-alpha responses by viral protein or dsRNAPhilippe Fournier, Jinyang Zeng, Volker Schirrmacher
International Journal of Oncology|July 16, 2004
High cell surface expression of Newcastle disease virus proteins via replicon vectors demonstrates syncytia forming activity of F and fusion promotion activity of HN moleculesJinyang Zeng, Philippe Fournier, Volker Schirrmacher
Pageof 13